Vivera Enters $23 Billion Telehealth Industry with Patent Allowance for MDZone

NEWPORT BEACH, Calif., April 21, 2022 /PRNewswire/ -- Vivera Pharmaceuticals, Inc. is pleased to announce that it has received a Notice of Allowance for U.S. Patent Application No. 17/066,985 entitled, "Self-Contained, Portable, Sanitization Device and Telemedicine Station," for the...

Click to view original post